Wednesday, June 10, 2015 9:51:57 PM
New Dividends CEO Shareholders Updates.
DALLAS, TX – June 11th, 2015 – SutimCo Inc.
(OTC PK: SUTI) ("The Company")
The CEO and the company would like to issue the following updates and clarifications as to the recent announcements concerning the dividends.
The company’s intent is to reward the shareholders with a dividend. The current record date is slated for October 1st, 2015. All shareholders of record holding shares of SUTI,
on the record date of October 1st, 2015, will receive a dividend via shares of SUTI.
The dividend formula is; 100 to 1. Example, for every 100 shares of SUTI held by a shareholder, the company will issue 1 share as a dividend. (1,000 shares held= 10 shares as a dividend.)
“We hope that will clear up any confusion as to the ratio of the dividend. The share- holder of the record date, need not to do anything, since the dividend will be issued automatically based on the shareholders position on the record date.” Stated CEO, Mr. Saenz.
Recent Developments:
“I’m extremely excited by this opportunity. I come from this market arena and look forward to growing and expanding the company’s reach in this market sector. As I took over the management in these past few weeks, I’ve already began the process of completing the past projects while introducing new and exciting developments to increase the growth and shareholders value. Here are several developments that are being processed now.”
1. Placing a shares reserve and managing the completion on a dividend distribution for our sister company PRPM.
2. Initiating and filing for the name change and stock symbol change. (In order to have a better branding position and more focus towards being identified in a Cannabis and/or Marijuana markets and sectors.)
3. Initiated our own “shareholders rewards program” by approving for a 100 to 1 company dividend with corporate action record date of October 1, 2015.
4. Completing the spin off the current SUTI CO and its assets/liabilities. (This should positively impact our balance sheet and financials with over $ 3.5 million reductions in the liabilities columns).
5. Developing a comprehensive acquisitions and investment plan for Q3, and Q4 2015.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM